Hostname: page-component-7b7567c8c-mnklg Total loading time: 0 Render date: 2026-11-12T17:05:44.350Z Has data issue: false hasContentIssue false

Challenges and strategies for recruitment of minorities to clinical research and trials

Published online by Cambridge University Press:  13 June 2023

Susan P. Fisher-Hoch
Affiliation:
UTHealth Houston School of Public Health, Brownsville Campus, Brownsville, TX, USA
Jennifer E. Below
Affiliation:
Vanderbilt University Medical Center, Division of Genetic Medicine, Nashville, TN, USA
Kari E. North
Affiliation:
University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA
Joseph B. McCormick*
Affiliation:
UTHealth Houston School of Public Health, Brownsville Campus, Brownsville, TX, USA
*
Corresponding author: J. B. McCormick, MD; Email: joseph.b.mccormick@uth.tmc.edu
Rights & Permissions [Opens in a new window]

Abstract

Minority populations are largely absent from clinical research trials. The neglect of these populations has become increasingly apparent, with escalating cancer burdens and chronic disease. The challenges to recruitment of minorities in the United States are multiple including trust or lack thereof. Keys to successful recruitment are responding to community issues, its history, beliefs, and its social and economic pressures. The strategy we have used in many low-income, sometimes remote, communities is to recruit staff from the same community and train them in the required basic research methods. They are the first line of communication. After our arrival in the Texas Rio Grande Valley in 2001, we applied these principles learned over years of global research, to studies of chronic diseases. Beginning in 2004, we recruited and trained a team of local women who enrolled in a cohort of over five thousand Mexican Americans from randomly selected households. This cohort is being followed, and the team has remained, acquiring not only advanced skills (ultrasound, FibroScan, retinal photos, measures of cognition, etc.) but capacity to derive key health information. Currently, we are participating in multiple funded studies, including an NIH clinical trial, liver disease, obesity, and diabetes using multiomics aimed at developing precision medicine approaches to chronic disease prevention and treatment.

Information

Type
Special Communications
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Association for Clinical and Translational Science